Last Updated: November 20, 2026

Dainik Savera Times Logo

  • Shivraj Singh Chouhan to Launch India’s First Indigenous H5N1 Bird Flu Vaccine for Poultry Today

    November 20, 2026

    Shivraj Singh Chouhan to Launch India’s First Indigenous H5N1 Bird Flu Vaccine for Poultry Today

    New Delhi: Union Minister for Agriculture and Farmers’ Welfare Shivraj Singh Chouhan will dedicate India’s first inactivated H5N1 vaccine for poultry to the country on Friday (November 20).

    Developed by the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, the vaccine aims to help prevent disease transmission in poultry.

    Highly Pathogenic Avian Influenza (HPAI/H5N1) is a serious disease for poultry and can lead to entire flocks of poultry dying. This means mass culling operations are often required, and trade restrictions are enforced.

    It also effects global markets, increasing prices of poultry products, and causing large economic losses in farms.

    Over 500 Cases Of Bird Flu In India Since 2006

    Bird flu was first recorded in India in 2006. Since then, over 500 cases of bird flu have occurred. These cases involve both H5N1 and H5N8 strains.

    Should a large outbreak occur within the country, it is estimated that India’s GDP growth would fall by 1.5% and over 20% of the poultry population could be at risk.

    In previous years, bird flu has had significant economic impacts. During an outbreak in 2006, it is estimated that direct and indirect costs ranged between Rs 2200 crores and Rs 3000 crores. In another outbreak in Manipur, economic loss equated to 0.5% of the state’s GDP.

    Bird Flu (H5N1) Can Pose A Risk To Humans

    H5N1 poses risks to human health too.

    Since 2003, 1003 cases of H5N1 avian influenza have been reported worldwide. Within these cases, 479 people have died. The disease has been reported in 25 countries, including in India.

    Studies on the virology of bird flu have found that the majority of cases in poultry are caused by the H5N1 Clade 2.3.2.1a strain. Recently, infections have been seen in mammals, as well as three cases in humans.

    Previously, there has been no specific commercial vaccine available to protect poultry from the current circulating Clade 2.3.2.1a strain.

    However, this vaccine developed in India by ICAR-NIHSAD should help protect poultry from the current circulating strain. It aims to reduce economic loss for farmers and reduce transmission of the virus to other animals and humans from poultry.

    There is more news...